The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Share News (PRM)

Share Price Information for Proteome (PRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.43
Bid: 3.06
Ask: 3.80
Change: -0.17 (-4.72%)
Spread: 0.74 (24.183%)
Open: 3.60
High: 0.00
Low: 0.00
Prev. Close: 3.60
PRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: IG Design Gets CSS Boost; FireAngel In Virus Hit

Mon, 25th Jan 2021 16:17

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

IG Design Group PLC - consumer gift packaging business - For nine months to the end of December, revenue rises by 35% year-on-year to USD737 million, mainly due to the acquisition of CSS Industries Inc, first announced at the start of 2020. However, revenue excluding CSS is 9.2% lower. Due to the CSS addition, adjusted pretax profit for the nine-month period is higher than the year before. Looking ahead, IG Design's full year outlook remains in line with market expectations, as ongoing restrictions create continued uncertainty.

----------

FireAngel Safety Technology Group PLC - Coventry-based fire safety products firm - For 2020, sales expected to be down 12% year-on-year at GBP39.9 million from GBP45.5 million, due to the operational and market disruption caused by Covid-19, as well as delays on making progress in its Connected Homes strategy. However, noted strong recovery in second half. Looking ahead, company applies for increased Coronavirus Large Business Interruption Loan Scheme to provide further headroom and support revenue growth.

----------

Proteome Sciences PLC - drug development services provider - For 2020, expects posttax profit of GBP30,000, up from GBP20,000 the year before, on revenue that remains unchanged from GBP4.6 million the prior year. Proteome Services business revenue rises by 56% year-on-year to GBP1.5 million, while TMT and TMTpro sales accounts for GBP3.1 million. Looking ahead, company expects further growth in TMT and TMTpro.

----------

Anexo Group PLC - Liverpool-based legal services provider - For 2020, expects adjusted pretax profit to be in line with market expectations, as revenue growth beats company expectations as group remains operational throughout national lockdowns. In 2019, adjusted pretax profit was GBP23.1 million, on revenue of GBP78.5 million. Average number of vehicles on road in 2020 set to beat that of 2019, due to record numbers reached in second half of 2020.

----------

Inspiration Healthcare Group PLC - West Sussex-based medical technology company - For the year to the end of January, due to a strong performance from recent acquisition and ventilator designer SLE Ltd, expects earnings before interest, taxes, depreciation and amortisation of at least GBP4.9 million, on revenue of no less than GBP36.5 million. For the year before, Ebitda was GBP2.1 million, on revenue of GBP17.8 million.

----------

Sopheon PLC - enterprise software provider - Notes that final quarter of 2020 was the strongest for the group, despite the resurgence of Covid concerns. Total contract value of signed Software-as-a-Service business more than tripled year-on-year, while annual recurring revenue gross retention was at 91.5%, compared to 94.2% the year before. Looking ahead, company expects 2020 adjusted earnings before interest, taxes, depreciation and amortisation at USD5.6 million, down from USD6.4 million the year before. This is on revenue that is set to be around USD30 million, compared to USD30.3 million in 2019, and annual recurring revenue that is expected to rise to USD18 million from USD15.9 million. For 2021, ARR visibility is at USD22 million

----------

Filta Group Holdings PLC - commercial kitchen cleaning services provider - In 2020, delivers a much stronger performance in the second half, as customer numbers rise during the summer period. In the US and UK, demand starts to pick up in the second half quicker than expected, due to the return of customers. Cash and cash equivalents position at year-end as at December 31 is GBP4.2 million, up 45% from GBP2.9 million.

----------

Distribution Finance Capital Holdings PLC - bank providing personal savings products - For 2020, raises around GBP145 million in deposits. As at December 31, the loan book reached GBP113 million, up 36% from GBP83 million in October. As at Friday last week, loan book now stands at GBP125 million.

----------

Yellow Cake PLC - Jersey-based uranium investor - As at December 31, net asset value per share is GBP2.44, down from GBP2.56 at the end of September. Value of uranium oxide in concentrates is USD279.5 million, marginally higher from USD277.2 million as at September 30.

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
20 Nov 2013 07:52

AIM IN BRIEF: Rangers FC Appoints Graham Wallace As CEO

Read more
30 Sep 2013 09:26

Proteome Sciences Losses Widen Despite Revenue Growth; Signs USD2.1M Contract

Read more
18 Sep 2013 15:03

Proteome Expects Strong Second-Half Growth After Making Alzheimer's Progress

Read more
12 Jun 2013 11:37

Proteome Sciences to develop cancer pathway profiling assays

AIM-listed biotech group Proteome Sciences has unveiled its largest contract to date comprising a technology agreement with Thermo Fisher Scientific, to develop advanced methods to profile changes in cancer pathways. Proteome Sciences said that the contract - which it valued at £2.1m - would prov

Read more
18 Mar 2013 14:29

Proteome Sciences looks ahead with confidence

Drug developer Proteome Sciences has told investors that it expects strong revenue growth across the company's three main divisions in 2013 and said it is 'much encouraged by the prospects'. The announcement comes after the group received a positive response to the presentation of four posters tha

Read more
31 Dec 2012 12:50

STOCKS NEWS EUROPE-UK small caps closes modestly higher

The FTSE Small Caps index closes 0.1 percent higher on Monday, New Year's Eve, tracking similar modest gains by the mid caps, also up 0.1 percent, while the blue chips shed 0.5 percent after a half-day session. The small caps index has gained 24 percent over 2012, just outperforming a 22 percent adv

Read more
31 Dec 2012 10:48

Proteome delivers encouraging results from Alzheimers study

Drug maker Proteome Sciences has completed the in-vivo study of its CK1D inhibitor programme in Alzheimer's disease on time, with the results showing that both of the lead compounds for CK1D demonstrated improved cognitive function. The firm said the results provide important in-vivo proof of prin

Read more
28 Sep 2012 10:46

Proteome Sciences narrows losses, bright outlook

Proteomics specialist Proteome Sciences reduced half year losses and expects second half revenues to be significantly boosted as it doubles the number of biomarker tests available from PS Biomarker Services. The group expects major licences and contracts from its proprietary biomarkers and services

Read more
18 Sep 2012 10:57

Proteome stroke test could save thousands from brain damage

Medical technology group Proteome Sciences has released details of a study into a blood test which could reduce brain damage in thousands of stroke victims. The group has been collaborating with researchers at the University of Geneva to produce the test which can tell how long ago a stroke actuall

Read more
20 Aug 2012 07:43

London pre-open: Doubts about further Chinese stimulus

City sources predict the FTSE 100 will open up five points from Friday's close of 5,852, having gained 18 points during Friday's session following positive data from the US. Over the weekend it was reported in Europe by the Handelsblatt newspaper that the European Union could appoint the European

Read more
20 Aug 2012 07:20

Proteome Sciences reports collaboration research agreement

Biotech group Proteome Sciences has agreed to work with CHDI Foundation Inc on a systems biology project regarding Huntington's disease. Initially, Proteome will provide its PS Biomarker Services protein profiling to CHDI's research programmes. The analyses will be performed at Proteome's facility

Read more
5 Apr 2012 11:50

Proteome issues new licence for stroke product

Pharma group Proteome Sciences has granted a non-exclusive licence to UK firm Randox Laboratories for its portfolio of stroke biomarkers. Under the terms of the agreement Randox will develop products for early diagnosis of stroke and subsequent monitoring of treatment outcomes. Proteome will ear

Read more
28 Mar 2012 10:46

Proteome rockets on Alzheimer's blood test

Pharma group Proteome Sciences has had a strong morning on the markets after announcing success in its project to develop better diagnostic tools for Alzheimer's disease. A study of 1,000 patients has shown three distinct "biomarkers" in people's blood which can discriminate between mild "cognitive

Read more
19 Mar 2012 10:17

Stroke consortium to get €11m grant

Shares in biomarker specialist Proteome Sciences rose almost 5% on Monday morning after it announced the EU was to award €11m to a consortium of which it is a member. Euro-HYP-1, a consortium of academic, clinical and industrial European partners that includes Proteome, has been awarded the grant f

Read more
27 May 2011 12:09

Proteome boosted by Sanofi settlement

Biomarker specialist Proteome Sciences is back in profit after receiving €11m from Sanofi-Aventis to settle a warranty claim. The company posted pre-tax profits of £4.59m in the year to the end of December, including the warranty claim. This compared £4.20m pre-tax loss in 2009. Revenues for 2010

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.